Singapore: National Institutes of Health (NIH) Clinical Center has suspended operations of its Pharmaceutical Developmen...
Singapore: Researchers at the National Institutes of Health (NIH) have identified a potential new drug that could help i...
Singapore: Alexion pharma has announced the submission of New Drug Application (NDA) to the Japanese Ministry of Health,...
Singapore: Japanese pharma major Takeda Pharmaceutical Company has announced that the randomized, double-blind, placebo-...
Singapore: A phase II interim analysis of a randomized study involving Boehringer Ingelheim's investigational haematolog...
Singapore: Australian biotechnology company Minomic International has collaborated with US partner to develop a potentia...
Singapore: The US Food and Drug Administration (FDA) has granted Genmab and GlaxoSmithKline (GSK) breakthrough therapy d...
Singapore: According to an international multiple sclerosis (MS) registry and a US health claims database, Novartis' Gi...
Singapore: Gilead Sciences has expanded its agreement with Ireland based Janssen for the development and commercializati...
Tokyo: Shionogi, one of Japan's century-old pharmaceutical manufacturers, has announced that its once-daily naldemedine ...
Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a res...
Singapore: Taiwan's PharmaEngine licensing partner, Merrimack Pharmaceuticals, and its sublicensing partner, Baxter Inte...
Singapore: HUYA Bioscience International has signed an exclusive license with Fudan University for the ex-China rights t...
Singapore: Australia-based drug discovering company, Phylogica has inked a pact with US-based Genentech, to discover nov...
Singapore: Pharma giant Pfizer has received a complete response letter from the US Food and Drug Administration (FDA) o...
Singapore: Taiwan's PharmaEngine has recieved Taiwan Food and Drug Administration (TFDA) approval for ONIVYDE (irinoteca...
Singapore: Australia-based Cellmid has received patent approval from IP Australia for method of treatment or prevention ...
Singapore: Global pharmaceutical firm, Pfizer, has recieved US Food and Drug Administration (FDA) nod for review of Biol...
